Eyenovia, Inc.
(NASDAQ : EYEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.95%42.960.9%$1172.19m
LLYEli Lilly and Company
1.04%124.001.0%$1160.63m
JNJJohnson & Johnson
0.86%136.590.6%$960.96m
MRKMerck & Co., Inc.
1.12%80.720.6%$933.10m
BMYBristol-Myers Squibb Company
1.70%50.981.4%$779.97m
ABBVAbbVie, Inc.
1.60%80.012.2%$667.49m
AZNAstraZeneca PLC Sponsored ADR
1.27%40.951.3%$191.16m
NVSNovartis AG Sponsored ADR
0.30%90.780.2%$183.03m
GSKGlaxoSmithKline plc Sponsored ADR
0.03%40.550.2%$135.60m
NVONovo Nordisk A/S Sponsored ADR Class B
0.28%49.800.1%$67.28m
SNYSanofi Sponsored ADR
-0.36%41.180.2%$36.78m
LCILannett Company, Inc.
0.64%9.4136.7%$16.84m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.70%1.801.7%$0.06m
EPIXESSA Pharma Inc
1.96%3.640.1%$0.04m

Company Profile

Eyenovia, Inc. is an emerging growth clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The company was founded on March 12, 2014 and is headquartered in New York, NY.